Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
980.08
979.00
879.47
1,057.60
1,817.35
1,334.33
879.51
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
980.08
979.00
879.47
1,057.60
1,817.35
1,334.33
879.51
Raw Material Cost
652.83
652.66
623.91
824.05
1,494.62
1,012.59
678.75
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
162.89
180.37
178.52
216.54
298.06
210.05
174.41
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.85
6.92
4.80
3.27
3.62
1.16
2.00
Selling and Distribution Expenses
139.83
174.97
140.79
133.48
175.47
143.78
109.41
Other Expenses
-7.99
-9.58
-8.08
-8.93
-15.87
-11.81
-10.99
Total Expenditure (Excl Depreciation)
879.49
919.15
867.25
1,088.07
1,813.07
1,249.48
854.64
Operating Profit (PBDIT) excl Other Income
100.60000000000001
59.800000000000004
12.2
-30.5
4.3
84.80000000000001
24.900000000000002
Other Income
13.56
30.85
27.31
39.75
8.90
-10.45
10.60
Operating Profit (PBDIT)
137.81
112.24
74.44
10.01
36.56
92.24
54.50
Interest
3.85
6.92
4.80
3.27
3.62
1.16
2.00
Exceptional Items
-16.63
-12.45
-0.07
-15.22
-7.91
-0.54
2.13
Gross Profit (PBDT)
327.25
326.34
255.56
233.55
322.73
321.74
200.76
Depreciation
29.81
30.11
32.91
34.61
27.76
17.93
16.91
Profit Before Tax
87.52
62.76
36.66
-43.09
-2.73
72.61
37.73
Tax
4.08
1.88
1.91
-6.37
-2.93
4.03
6.96
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
82.00
61.36
34.37
-32.36
8.87
70.16
31.06
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
82.00
61.36
34.37
-32.36
8.87
70.16
31.06
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.73
-3.21
-3.17
-5.84
-9.14
-2.27
-1.17
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
80.27
58.16
31.20
-38.20
-0.28
67.89
29.89
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,024.42
996.17
1,040.60
1,012.13
1,054.84
653.56
568.18
Earnings per share (EPS)
0.38
0.28
0.16
-0.15
0.04
0.37
0.16
Diluted Earnings per share
0.38
0.28
0.16
-0.15
0.04
0.37
0.16
Operating Profit Margin (Excl OI)
9.64%
5.24%
1.62%
-6.08%
-0.01%
6.35%
3.07%
Gross Profit Margin
11.97%
9.49%
7.91%
-0.8%
1.38%
6.79%
6.21%
PAT Margin
8.37%
6.27%
3.91%
-3.06%
0.49%
5.26%
3.53%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 0.11% vs 11.31% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 37.97% vs 86.54% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 52.58% vs 72.82% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -44.93% vs 43.75% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Guangdong Transtek Medical Electronics Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
980.08
0
980.08
Other Operating Income
0.00
0.00
0.00
Total Operating income
980.08
0
980.08
Raw Material Cost
652.83
0
652.83
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
162.89
0
162.89
Power Cost
0
0
0.00
Manufacturing Expenses
3.85
0
3.85
Selling and Distribution Expenses
139.83
0
139.83
Other Expenses
-7.99
0.00
-7.99
Total Expenditure (Excl Depreciation)
879.49
0
879.49
Operating Profit (PBDIT) excl Other Income
100.59
0.00
100.59
Other Income
13.56
0
13.56
Operating Profit (PBDIT)
137.81
0
137.81
Interest
3.85
0
3.85
Exceptional Items
-16.63
0
-16.63
Gross Profit (PBDT)
327.25
0
327.25
Depreciation
29.81
0
29.81
Profit Before Tax
87.52
0
87.52
Tax
4.08
0
4.08
Provisions and contingencies
0
0
0.00
Profit After Tax
82.00
0
82.00
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
82.00
0
82.00
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.73
0
-1.73
Other related items
0.00
0.00
0.00
Consolidated Net Profit
80.27
0
80.27
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,024.42
0
1,024.42
Earnings per share (EPS)
0.38
0
0.38
Diluted Earnings per share
0.38
0
0.38
Operating Profit Margin (Excl OI)
9.64%
0%
0.00
9.64%
Gross Profit Margin
11.97%
0%
0.00
11.97%
PAT Margin
8.37%
0%
0.00
8.37%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 98.01 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 0.11% vs 11.31% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 8.03 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 37.97% vs 86.54% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.42 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 52.58% vs 72.82% in Dec 2024
Annual - Interest
Interest 0.38 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -44.93% vs 43.75% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.64%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






